Revolutionizing Immunotherapy TreatmentCare
Pioneering next-generation immunotherapy to transform invisible cancer cells into visible targets
Unlocking the Power of Immune Engineering
Pioneering immune-engineering platforms designed to detect, engage, and resolve disease through next-generation innovation.
The Future starts with LurexBio
Lurex Bio is pioneering next-generation immune engineering and therapeutic delivery systems designed to overcome tumor immune evasion.
Proprietary Platforms
Lurex Bio's technology stack represents a unified approach to immune engineering. Each platform—NeoTag™, Atraxis™, Atraxis-X™, and DeltaGate Logic™—addresses a distinct layer of immune activation, from tumor tagging and membrane fusion to adaptive signal control. Together, these platforms form a modular architecture that transforms immune-silent tumors into visible, targetable cells while maintaining precision, safety, and scalability across multiple disease categories.
Immune Tagging
Precision immune-tagging platform that identifies and flags immune-silent tumor cells for recognition
Learn More
Immune Fusion
Innovative immune-engineering platform that unites synthetic immune cues with tumor biology to restore recognition.
Learn More
Precision Control
Advancing the Atraxis platform through adaptive technology that delivers precision control and timing in therapeutic deployment.
Learn More
Adaptive Logic
Adaptive bio-decision logic system delivering precision and safety across diverse disease applications while protecting healthy tissue
Learn MoreHow Our Platforms Work
A unified system of next-generation technologies that redefines how the immune system sees and responds to disease — with broad potential across oncology, autoimmune, and other immune-driven conditions. The adaptive delivery architecture also offers opportunities for collaboration and licensing, enabling precision delivery of therapeutic agents across the biotech and pharmaceutical landscape.
-
01.
Synthetic Immune Signals
NeoTag™ is designed to apply engineered immune markers that enable immune-silent tumor cells to become visible to the body's defenses.
-
02.
Precision Delivery
The Atraxis™, Atraxis-X™, and DeltaGate Logic™ platforms are designed to coordinate precision-timed therapeutic engagement, enabling controlled activation within cold tumor environments while safeguarding healthy tissue.
-
03.
Immune Activation
DeltaGate Logic™ is designed to orchestrate precision immune engagement, restoring targeted immune awareness against tumors that evade detection.
At LurexBio, we’re reimagining immunotherapy with precision, simplicity, and a relentless focus on clinical impact. Get to know the experts and industry professionals shaping the future of immune‑based medicine.
The Road Ahead
Our forward‑looking strategies offer clear visibility into our priorities, deliverables, and expected impact. Explore our active programs and development pipelines to see what’s driving our next phase of innovation.
Latest News
Featured In
